Psoriatic Arthritis Clinical Trial Opportunity
If you have been diagnosed with psoriatic arthritis then you may qualify for our observational research study.
THE KEY TO THE FUTURE IS YOU
Psoriatic arthritis is a chronic inflammatory condition that can affect those with psoriasis who also develop joint pain. Only about 15 percent of those with psoriasis develop this arthritis.
There are many medications available to those who have psoriatic arthritis, most of which aim to reduce inflammation and pain. Some may even slow the progress of the condition by preserving the bone around the joints. Additionally, there are medications targeted at the immune system itself.
Unfortunately, up to about 40 percent of psoriatic arthritis patients may not achieve meaningful improvement of their symptoms with current medication options.
Do You Qualify?
Not everyone with psoriatic arthritis will qualify for this study. There are specific criteria patients must meet. Here is a list of the most basic criteria:
- Have d/o psoriatic arthritis, for at least 6 months
- Be between 18-80 years old
- Have obesity
- Have no prior exposure to Taltz (ixekizumab), tirzepatide (zepound or mounjaro) or diabetes requiring insulin to control
- Be able and willing to travel to north Houston for appointments
You may fit all of these eligibility requirements, but some additional criteria may make you ineligible.
HELP MAKE IMPROVED PsA TREATMENTS A REALITY BY SIGNING UP FOR THIS INNOVATIVE RESEARCH STUDY
If you’d like to be a part of the study, click the button below or call 936-251-6831 and ask for a member of the clinical research division. Our team can help evaluate your eligibility for the study.
Note: participation in this study requires frequent visits to our clinic in The Woodlands. We recommend interested patients be located in Houston or the surrounding area.